Skip to main content

Month: July 2020

Otonomy Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

SAN DIEGO, July 13, 2020 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced the closing of its previously announced underwritten public offering of 17,275,000 shares of its common stock, which includes the underwriters’ full exercise of their option to purchase additional shares and pre-funded warrants to purchase up to 4,000,000 shares of its common stock, for total gross proceeds of approximately $69.1 million, before deducting the underwriting discounts and commissions and other offering expenses payable by Otonomy. All of the securities were sold by Otonomy.Cowen and Piper Sandler acted as active joint book-running managers for the offering. Cantor Fitzgerald & Co. acted as bookrunner and H.C. Wainwright...

Continue reading

Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

REDWOOD CITY, Calif., July 13, 2020 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq:RVMD), a clinical-stage oncology company focused on developing targeted therapies to inhibit elusive frontier targets within notorious cancer pathways, today announced the closing of an underwritten public offering of 6,900,000 shares of common stock at a public offering price of $26.00 per share, before underwriting discounts and commissions. The shares of common stock issued and sold in the offering include 900,000 shares issued upon exercise in full by the underwriters of their option to purchase additional shares of common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Revolution...

Continue reading

Immunomedics Expands Collaboration with Roche Evaluating Trodelvy™ (sacituzumab govitecan-hziy) in Combination with Tecentriq® (atezolizumab) into Urothelial and Non-Small Cell Lung Cancers

Companies have ongoing collaboration in first-line metastatic triple-negative breast cancerImmunomedics also announces Phase 2 NeoSTAR study in neoadjuvant triple-negative breast cancer has begun patient enrollmentMORRIS PLAINS, N.J., July 13, 2020 (GLOBE NEWSWIRE) — Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today announced an extension of its current clinical collaboration with Roche to evaluate Trodelvy, Immunomedics’ anti-Trop-2 ADC, in combination with Tecentriq, Roche’s programmed cell death ligand 1 (PD-L1)-blocking checkpoint inhibitor (CPI), in patients with metastatic urothelial cancer (mUC) and metastatic non-small cell lung cancer (mNSCLC).“Given that Trodelvy can cause tumor-cell death with possible neoantigen...

Continue reading

America’s Car-Mart Opens New Dealership in Cabot, AR

Rogers, Arkansas , July 13, 2020 (GLOBE NEWSWIRE) — America’s Car-Mart, Inc. (NASDAQ: CRMT) today announced the opening of a new dealership located in Cabot, AR.  This will be the thirty-eighth dealership in Arkansas, the first dealership opening in fiscal year 2021 and our 149th dealership.  The dealership will be managed by Dennis Johnson, with the assistance of Chris Martin.  This will be the second dealership managed by Mr. Johnson as we look to expand the number of customers served by our top performing general managers.“A great deal of thought and foresight is placed on our decisions about where to grow. We select communities where we believe we can fill a void when it comes to what we offer at Car-Mart,” said Jeff Williams, President and Chief Executive Officer, “We’re different from traditional dealerships. In addition to...

Continue reading

Ingredion to Release 2020 Second Quarter Financial Results on Tuesday, August 4, 2020

WESTCHESTER, Ill., July 13, 2020 (GLOBE NEWSWIRE) — Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food manufacturing industry, will release its 2020 second quarter financial results for the period ended June 30, 2020, before the market opens on Tuesday, August 4, 2020.Jim Zallie, president and chief executive officer, and James Gray, executive vice president and chief financial officer, will host a conference call on August 4 at 8 a.m. CT to discuss the Company’s financial performance. The conference call and accompanying slide presentation will be webcast live at https://ir.ingredionincorporated.com/events-and-presentations. Participants are encouraged to log on to the webcast approximately 10 minutes before the start of the presentation. A replay of the presentation will be available...

Continue reading

TOGA Limited Names Marcum LLP as Auditor

LAS VEGAS, July 13, 2020 (GLOBE NEWSWIRE) — TOGA LIMITED (OTC: TOGL) (“Toga” or the “Company”) is pleased to announce that it has engaged Marcum LLP as its new independent registered public accounting firm to replace Pinnacle Accountancy Group of Utah.  The change of the Company’s independent registered public accounting firm was approved by the Audit Committee of its Board of Directors on July 10, 2020Contact:Alexander D. HendersonTOGA LIMITED2575 McCabe Way, Suite 100Irvine, CA 92614(949) 333-1603

Continue reading

Pzena Investment Management Appointed by St. James’s Place as Co-Manager of Its Global Value Fund

NEW YORK, July 13, 2020 (GLOBE NEWSWIRE) — Pzena Investment Management announced its appointment by St. James’s Place PLC as a manager in its Global Value Fund. Pzena will manage 50% of the fund based on its Global Focused Value strategy, its flagship global strategy managed since 2004.William Lipsey, President of Pzena commented: “Our appointment marks an important milestone in our firm’s history, coming as it does 25 years since the firm’s inception and five years since we opened our London office. Pzena has a proud history of partnering with sophisticated, long-term clients around the world. St. James’s Place is the leading wealth manager in the UK with an impressive history of growth and innovation in the UK retail market who share our commitment to achieving long-term investment success for clients.”Rich...

Continue reading

Nevada Copper Announces $97 Million Bought Deal Public Offering; And Proposed Retirement of Convertible Debt

All dollar amounts are presented in Canadian dollars unless otherwise noted.YERINGTON, Nev., July 13, 2020 (GLOBE NEWSWIRE) — Nevada Copper Corp. (TSX: NCU) (“Nevada Copper” or the “Company’’) is pleased to announce that it has entered into an agreement with Scotiabank, on behalf of a syndicate of underwriters including RBC Capital Markets and National Bank Financial Inc., acting together with Scotiabank as joint Bookrunners, and including Haywood Securities (collectively, the “Underwriters”), pursuant to which the Underwriters have agreed to buy on a bought deal basis 643,713,553 units of the Company (the “Units”) at a price of $0.15 per Unit (the “Offering Price”) for aggregate gross proceeds of approximately $97 million (the “Offering”).Each Unit consists of one common share of Nevada Copper (a “Common Share”) and one-half of...

Continue reading

Willis Towers Watson to Announce Second Quarter Earnings on July 30, 2020

ARLINGTON, Va. and LONDON, July 13, 2020 (GLOBE NEWSWIRE) — Willis Towers Watson (NASDAQ: WLTW), a leading global advisory, broking and solutions company, will announce its financial results for the second quarter 2020 on Thursday July 30, 2020.The company will host a conference call to discuss its financial results at 9:30 a.m. Eastern Time on July 30, 2020. A live broadcast of the conference call will be available online at the Investor Relations section of www.willistowerswatson.com.An online replay at www.willistowerswatson.com will be available shortly after the call.  A telephonic replay of the call will also be available for 24 hours at 404-537-3406, conference ID 2568649.ABOUT WILLIS TOWERS WATSONWillis Towers Watson (NASDAQ: WLTW) is a leading global advisory, broking and solutions company that helps clients around the...

Continue reading

TAAT LIFESTYLE & WELLNESS LTD. Signs Letter of Intent to Acquire Leading U.S. Hemp Cigarette Brand Sold In Over 1,600 Retail Locations

Oregon-based Redwood is a “seed-to-smoke” hemp company that offers a lineup of premium, high-quality smokable products made with its own organically-grown hemp. Redwood’s product selection is carried in more than 1,600 U.S. retail stores, which the Company intends to leverage to make Beyond Tobacco™ available to a wider audience of retailers upon its much-anticipated launch planned to occur in Q4 2020. As a result of the proposed acquisition, TAAT plans to benefit from Redwood’s broad production capacity and possibly reduce the cost of producing Beyond Tobacco™ by as much as 50%. Further information regarding this acquisition will be shared in a public conference call to be held at 3:00 pm PDT / 6:00 pm EDT today.LAS VEGAS and VANCOUVER, British Columbia, July 13, 2020 (GLOBE NEWSWIRE) —  TAAT LIFESTYLE & WELLNESS LTD. (CSE:...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.